Ropes & Gray advised CAMP4 Therapeutics in a research collaboration with BioMarin Pharmaceutical aimed at advancing novel therapeutics that increase protein levels by targeting regulatory RNA sequences, which are key in controlling gene expression. The collaboration was announced on October 1.
Under the agreement, BioMarin will select two targets identified through CAMP4’s RAP Platform for development. CAMP4 will receive an upfront payment and is eligible for additional milestone payments and tiered royalties based on collaboration success. The collaboration allows CAMP4 to expand its platform to additional therapeutic targets and strengthens BioMarin’s position in genetic medicines.
The Ropes & Gray team included life sciences licensing partner Hannah England and life sciences licensing associate Ian Nilsen.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.